MALARIA DIAGNOSTICS MARKET ANALYSIS

Market Challenges And Opportunities

Market Restraints:

1. Rising number of malaria-free countries is expected to hinder growth of the global malaria diagnostics market. For instance, a total of 12 countries were certified malaria free by the World Health Organization (WHO), between 2020 and 2022. Countries certified malaria free by the WHO include Morocco, United Arab Emirates, Turkmenistan, Argentina, Armenia, Paraguay, Uzbekistan, Kyrgyzstan, China, Algeria, Sri Lanka, and El Salvador.
2. Increasing demand for low-cost diagnostic tools is expected to hamper growth of the global malaria diagnostics market. For instance, Malaria is highly prevalent in the middle- and low-income countries and lacks access to proper public health facilities and affordable diagnostics. Thus, with the increase in prevalence of malaria, the demand for low-cost diagnostic tools is also increasing with a rapid pace. This in turn is expected to restrain market growth.

Market Drivers:

1. Increasing prevalence of malaria across the globe is expected to augment the growth of the global malaria diagnostics market over the forecast period. For instance, according to the World Malaria Report 2020, there were 241 million cases of malaria in 2020 (uncertainty range 218-269 million), compared to 227 million cases in 2019, and 627,000 malaria deaths (uncertainty range 583-765 thousand). Africa is the world region that is most affected by malaria. In 2019, 96% of global deaths from malaria occurred on the African continent.
2. Growing demand for diagnostic tools in malaria-endemic regions is expected to boost growth of the global malaria diagnostics market during the forecast period. For instance, in June 2019, PATH and Quansys Biosciences announced the launch of a highly sensitive malaria diagnostic tool designed to help researchers detect and treat malaria. The Q-Plex Human Malaria Array is a quantitative immunoassay that supports researchers in creating more sensitive malaria rapid diagnostic tests and will aid in public health surveillance.

Market Opportunities:

1. Government initiatives to prevent malaria is expected to offer lucrative growth opportunities for players in the global malaria diagnostics market. For instance, WHO’s (the World Health Organization’s) Global Malaria Programme (GMP) is responsible for coordinating the WHO's global efforts to control and eliminate malaria. Moreover, the Nigerian government launched a national malaria elimination program, ramping up the distribution of mosquito nets & access to drug therapies, and expanding a plan for vector management.
2. Growing demand for novel malaria diagnostic tools is expected to provide significant growth opportunities for players in the global malaria diagnostics market. For instance, in April 2019, Human Diagnostics Worldwide, Eiken Chemical Co., Ltd., and the Foundation for Innovative New Diagnostics (FIND) announced the launch of the first commercially available molecular diagnostic test for the detection of malaria caused by Plasmodium vivax parasites.